Literature DB >> 11757956

DYT1 mutation in primary torsion dystonia in a Serbian population.

T Major1, M Svetel, S Romac, V S Kostić.   

Abstract

Primary torsion dystonia (PTD) is a clinically and genetically heterogeneous movement disorder. A GAG deletion at position 946 in the DYT1 gene is responsible for most cases of autosomal dominant early-onset PTD. We analysed the DYT1 mutation in 50 patients from a Serbian population, selected according to the proposed guidelines for diagnostic testing: (a) 38 patients with PTD onset < 26 years, and (b) 12 patients with the disease onset +/- 26 years, but with at least one affected family member with early-onset dystonia. Only three apparently sporadic patients among the 50 individuals tested were positive for the GAG deletion in the DYT1 gene: one with typical, generalized, one with long-lasting, non-progressive segmental, and one with multifocal dystonia. Molecular analysis of relatives in 2 families revealed that the lack of family history was due to reduced penetrance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757956     DOI: 10.1007/s004150170045

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  3 in total

1.  Phenotypic differences in Dyt1 between ethnic groups.

Authors:  Woong-Woo Lee; Tae-Beom Ahn; Sun Ju Chung; Beom Seok Jeon
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  The Frequency of DYT1 (GAG Deletion) Mutation in Primary Dystonia Patients from Iran.

Authors:  Mohammad Hamid; Mohammad Taghi Akbari; Gholam Ali Shahidi; Zahra Zand
Journal:  Cell J       Date:  2011-04-21       Impact factor: 2.479

3.  High-throughput mutational analysis of TOR1A in primary dystonia.

Authors:  Jianfeng Xiao; Robert W Bastian; Joel S Perlmutter; Brad A Racette; Samer D Tabbal; Morvarid Karimi; Randal C Paniello; Andrew Blitzer; Sat Dev Batish; Zbigniew K Wszolek; Ryan J Uitti; Peter Hedera; David K Simon; Daniel Tarsy; Daniel D Truong; Karen P Frei; Ronald F Pfeiffer; Suzhen Gong; Yu Zhao; Mark S LeDoux
Journal:  BMC Med Genet       Date:  2009-03-11       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.